0
Pharmacotherapeutics: Pharmacotherapuetics |

Safety and Tolerability of Rupatadine Administered to Asthmatic Patients With Persistent Allergic Rhinitis

Paraschiva Postolache, PhD; Narcisa Vrinceanu, PhD; Liliana Chelaru; Cristina Lacatusi; Daniela Husanu; Oana Arghir, MD; Gabriela Jimborean, MD
Author and Funding Information

Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):971A. doi:10.1016/j.chest.2016.08.1075
Text Size: A A A
Published online

Extract

SESSION TITLE: Pharmacotherapuetics

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM

PURPOSE: To assess the safety and tolerability of treatment with Rupatadine 10mg/day for 12 months in subjects with Asthma and Persistent Allergic Rhinitis (PAR), included in pulmonary rehabilitation program. Rupatadine is a novel antihistamine approved recently in Europe for the treatment of allergic rhinitis (AR) and chronic idiopathic urticaria in adults.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
[Personalised medicine for the diagnosis and treatment of allergic diseases]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013;56(11):1531-7.
Allergic rhinitis: current options and future perspectives. Curr Opin Allergy Clin Immunol 2014;14(2):168-76.
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543